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A human protein required for the second 
step of pre-mRNA splicing is functionally 
related to a yeast splicing factor 
David S. Horowitz and Adrian R. Krainer 1 
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 USA 
We have identified a human splicing factor required for the second step of pre-mRNA splicing. This new 
protein, hPrpl8, is 30% identical to the yeast splicing factor Prpl8. In HeLa cell extracts immunodepleted of
hPrpl8, the second step of pre-mRNA splicing is abolished. Splicing activity is restored by the addition of 
recombinant hPrpl8, demonstrating that hPrpl8 is required for the second step. The hPrpl8 protein is bound 
tightly to the spliceosome only during the second step of splicing, hPrpl8 is required for the splicing of several 
pre-mRNAs, making it the first general second-step splicing factor found in humans. Splicing activity can be 
restored to hPrpl8-depleted HeLa cell extracts by yeast Prpl8, showing that important functional regions of 
the proteins have been conserved. A 90-amino-acid region near the carboxyl terminus of hPrpl8 is strongly 
homologous to yeast Prpl8 and is also conserved in rice and nematodes. The homology identifies one region 
important for the function of both proteins and may define a new protein motif. In contrast to yeast Prpl8, 
hPrpl8 is not stably associated with any of the snRNPs. A 55-kD protein that cross-reacts with antibodies 
against hPrpl8 is a constituent of the U4/U6 and U4/U6 9 U5 snRNP particles. 
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The splicing of pre-mRNA takes place in two sequential 
transesterification reactions (for review, see Umen and 
Guthrie 1995c; Adams et al. 1996; Krgmer 1996). In the 
first step, the 2' hydroxyl group of an adenosine within 
the intron attacks the phosphate at the 5' splice site, 
forming the lariat intron-exon2 and exonl intermedi- 
ates. mRNA and lariat intron are produced in the second 
step by attack of the 3' hydroxyl group of exonl on the 
phosphate at the 3' splice site. The second reaction oc- 
curs within an assembled spliceosome that contains the 
U2, U5, and U6 small nuclear ribonucleoproteins 
(snRNPs) and a large number of proteins. 
Several proteins required specifically for the second 
step--Prp 16, Prp 17, Prp 18, and Slu7--have been studied 
in yeast, but in humans much less is known about the 
proteins involved in the second step (Umen and Guthrie 
1995c). PRP18 was discovered in a screen for yeast mu- 
tants that were temperature-sensitive for pre-mRNA 
splicing (Vijayraghavan etal. 1989). The Prp 18 protein is 
involved only in the second step of pre-mRNA splicing 
and is associated with the U5 snRNP (Vijayraghavan and 
Abelson 1990; Horowitz and Abelson 1993a,b). Prpl8 is 
not essential for yeast viability, although the second step 
of splicing is extemely slow without it. The sequence of 
~Corresponding author. 
E-MAIL krainer@cshl.org; FAX (516) 367-8453. 
Prpl8 is not instructive, and the precise function of 
Prp18 in the splicing reaction is not known. The Prp 16 
protein, initially found as a suppressor of a branch site 
mutation (Couto et al. 1987), is an RNA-dependent 
ATPase that catalyzes a conformational change in the 
spliceosome before the second splicing reaction (Schwer 
and Guthrie 1991, 1992). Prp17 is not an essential pro- 
tein, and its function in splicing remains unknown 
(Jones et al. 1995). Slu7, which was isolated based on its 
genetic interaction with the U5 snRNA (Frank et al. 
1992), is involved in the recognition of 3' splice sites 
(Frank and Guthrie 1992). Finally, the Prp8 protein, ini- 
tially shown to be a first-step splicing factor (Lustig et al. 
1986), is also required for the second step and appears to 
be involved in 3' splice-site recognition (Teigelkamp et 
al. 1995; Umen and Guthrie 1995a,b). 
Genetic studies suggest hat there is a network of in- 
teractions among these cond-step proteins (Frank et al. 
1992; Jones et al. 1995; Umen and Guthrie 1995b). Bio- 
chemical experiments have distinguished two stages 
within the second step. The first stage requires the Prp 16 
and Prp 17 proteins, as well as the hydrolysis of ATP; the 
second stage, during which the transesterification reac- 
tion occurs, requires Prpl8 and Slu7 and is independent 
of ATP (Schwer and Guthrie 1991; Horowitz and Abel- 
son 1993a; Ansari and Schwer 1995; Jones et al. 1995). 
In contrast to the progress in understanding the second 
GENES & DEVELOPMENT 11:139-151 9 1997 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/97 $5.00 139 
 Cold Spring Harbor Laboratory Press on December 11, 2013 - Published by genesdev.cshlp.orgDownloaded from 
Horowitz and Krainer 
step of splicing in yeast, little is known about the sec- 
ond-step roteins in human splicing. Two proteins, PSF 
and the U5-200-kD protein, appear to be involved in the 
second step of splicing (Gozani et al. 1994; Lauber et el. 
1996), but their precise functions are unknown. Frac- 
tions containing other activities needed for the second 
step have been described, but none has been purified suf- 
ficiently to allow identification of individual proteins 
(Krainer and Maniatis 1985; Perkins et el. 1986; Lindsey 
et el. 1995). The paucity of second-step factors known in 
humans led us to search for the homolog of Prpl8. 
Of the five splicing snRNPs, only three, the U2, U5, 
and U6 snRNPs, appear to be required for the second step 
(for review, see Ares and Weiser 1995; Umen and Guth- 
rie 1995c). The U2 and U6 snRNAs base-pair to each 
other and to the branch site and 5' splice site, forming 
structures necessary for both steps of splicing. A number 
of mutations in U2 or U6 specifically block the second 
step (Fabrizio and Abelson 1990; Madhani and Guthrie 
1992; McPheeters and Abelson 1992; Wolff et al. 1994). 
The U5 snRNA base-pairs to exonic sequences at both 
splice sites (Newman and Norman 1992), possibly align- 
ing the exons for splicing. 
Here we report the discovery of a new human protein 
required for the second step of splicing. The new protein 
is the homolog of the yeast splicing factor Prpl8. The 
yeast protein can substitute for the human one in the 
splicing reaction, showing that the mechanism of the 
pre-mRNA splicing reaction has been highly conserved 
in evolution. The sequence homology between the yeast 
and human proteins may define a new protein motif. 
Results 
Cloning of hPrpl8 by degenerate PCR 
The similarity of the yeast Prp 18 protein sequence to the 
translations of two short expressed sequence tag (EST) 
sequences from rice (133 amino acids) and nematode (83 
amino acids) suggested that they represent rue ho- 
mologs of Prpl 8. An alignment of the three sequences 
was used to design degenerate primers for PCR of human 
cDNA (Fig. 1). One of the resulting PCR fragments ap- 
peared from its sequence to be the desired one and was 
used to retrieve afull-length cDNA clone from a human 
cDNA library. The cDNA encodes anew protein, named 
hPrpl8, which is31% identical and 57% similar to yeast 
Prpl8 (Fig. 1A). hPrpl8 is 342 amino acids in length, 91 
amino acids longer than yeast Prp 18. Homology between 
the two proteins is strong in the carboxy-terminal third 
of the proteins (shown boxed in Fig. 1A) but weak else- 
where, where several gaps were introduced to give the 
displayed alignment, hPrp 18 is more similar to the rice 
and nematode EST sequence fragments than it is to yeast 
Prp 18, and a clear alignment of the four sequences can be 
made in the carboxy-terminal portion of hPrp 18 (Fig. 1B). 
hPrpl8 is not significantly homologous to any protein 
sequences in the data bases other than the three de- 
scribed here, and it has no known motifs. 
The role of hPrpl8 in pre-mRNA splicing 
To study the function of hPrpl8, the protein (with an 
amino-terminal histidine tag) was produced in Esche- 
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Figure 1. (A) Sequence homology of hPrpl8 and yeast Prpl8 proteins. An alignment of the hPrpl8 (hum) and yeast Prpl8 (yet) proteins 
is shown. The region of highest homology is boxed; positions of identity are shown white on black, positions of similarity, black on 
gray. Similarities used are D-E, R-K, T-S, V-I-L-M-F, W-Y-F, and N-Q. Termination is indicated by an asterisk. The 1450-bpDNA 
sequence ofthe hPrpl 8 gene has been deposited in GenBank under accession number U51990. (B) Phylogenetic conservation of the 
carboxy-terminal region of Prp 18. The alignment of hPrp 18, yeast Prp 18, and fragments ofpossible Prp 18 sequences from rice (D 15798) 
and nematode (T01256) using the same conventions as in A with the hPrpl8 numbering. Numbers at top are centered above th  
corresponding amino acid. A position is only shaded if at least three of the sequences are similar. The consensus sequence was derived 
from the lineup; positions of perfect or strong conservation are capitalized. At positions 272, 306, 307, and 324, where no amino acid 
is predominant, the amino acid from hPrpl 8 was arbitrarily chosen for the consensus. 
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richia coli and purified to near homogeneity. Polyclonal 
antibodies were raised against hPrpl8 and were used to 
deplete HeLa cell nuclear extracts of hPrp 18. A Western 
blot of control and immunodepleted extracts, probed 
with anti-hPrpl8, is shown in Figure 2A. Removal of 
hPrpl8 appears to be complete, because no residual 
hPrp 18 could be detected on long exposure of this blot. A 
cross-reacting protein with an apparent molecular mass 
of 55 kD was detected readily by anti-hPrpl8; however, 
it was not significantly depleted by the antibody. 
Splicing of p-globin pre-mRNA was assayed in normal 
and in anti-hPrpl 8 depleted extracts (Fig. 2B). In hPrpl 8- 
depleted extract, the second step of splicing was blocked 
almost completely (Fig. 2B, lanes 9-12). In untreated or 
pre-immune-depleted extracts (Fig. 2B, lanes 1-4, 5-8), 
splicing intermediates (exonl and lariat intron-exon2) 
were present at low levels during the reaction while the 
product mRNA accumulated. In anti-hPrpl8 depleted 
extract, the splicing intermediates accumulated during 
the reaction, and only a trace of mRNA was produced. 
Quantitation of the gel shown in Figure 2 with a Phos- 
phorImager showed that only the second step was af- 
fected by the depletion of hPrp18. The amounts of pre- 
mRNA remaining at each time point in the pre-immune- 
depleted and anti-hPrpl 8-depleted extracts are the same 
(to within 20%), as are the amounts of RNA processed 
through the first step (the sum of the molar amounts of 
intermediates and products). 
Purified recombinant hPrpl8 could restore full splic- 
ing activity to an anti-hPrpl8-depleted xtract (Fig. 2B, 
lanes 13-16). hPrpl8 was added to anti-hPrp18-depleted 
extract before the start of the splicing reaction; in this 
reconstituted extract (Fig. 2, lanes 13-16), the second 
step of splicing proceeded normally, producing mRNA at 
levels very similar to those in pre-immune-depleted ex- 
tract (<20% different from lanes 5-8 in Fig. 2). The first 
step of splicing was unaffected by the addition of hPrp 18. 
This result shows that hPrpl8 was the only essential 
splicing factor depleted by anti-hPrpl8 and establishes 
that hPrp 18 is required for the second step of pre-mRNA 
splicing. 
The splicing intermediates formed in the absence of 
hPrp 18 could be converted to products by the addition of 
hPrp 18. Splicing reactions were carried out for 90 min in 
the absence of hPrpl8 to form spliceosomes containing 
the lariat intron-exon2 and exonl intermediates (Fig. 3, 
lane 1). hPrpl8 was added to the reactions, and the 
amounts of intermediates and products were monitored 
(Fig. 3, lanes 5-8). Spliced product was formed rapidly on 
addition of hPrpl8 (Fig. 3, lane 5) and accumulated dur- 
ing the 30-min incubation (Fig. 3, lanes 6-8). Quantita- 
tion of this gel showed that the intermediates present 
after 90 min had been converted to products (Fig. 3B). 
The decrease in the amounts of intermediates was par- 
alleled by the increase in the amount of product mRNA. 
Because pre-mRNA levels were essentially constant for 
the first four time points (up to 16 rain), the mRNA 
formed must have come from chasing of the existing 
intermediates, not from de novo splicing of pre-mRNA. 
By 30 min, there is a decrease in the amount of pre- 
mRNA, perhaps because of the recycling of limiting 
spliceosomal components. 
To determine whether hPrpl8 is stably associated 
with spliceosomes during the splicing reaction, we tried 
to precipitate pre-mRNA, intermediates, or products 
from splicing reactions with antibodies against hPrpl 8. 
We found that very little RNA was immunoprecipitated 
by anti-hPrp 18 from standard splicing reactions (data not 
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Figure 2. (A) Immtmodepletion of hPrpl8 
from HeLa cell nuclear extracts9 A West- 
em blot probed with anti-hPrpl 8 showing 
untreated HeLa cell nuclear extract (lane 
1), the same xtract depleted with antibod- 
ies from pre-immune serum (lane 2), or 
with antibodies against hPrpl8 (lane 3). 
The positions of hPrpl8 and of a cross- 
reacting 55-kD protein (see text) are indi- 
cated, hPrpl8 was identified by its exact 
comigration with untagged hPrpl8 made 
in E. coli (with Mr-42,000 , near its pre- 
dicted size of 40,000; data not shown). 
Four pg of total protein was loaded in each 
lane. (B) Time course of pre-mRNA splic- 
ing in the presence and absence of hPrpl 8. 
Splicing of p-globin pre-mRNA (Krainer et 
al. 1984) was carried out using the extracts 
described in A: (Lanes I-4) Untreated; 
(lanes 5-8) pre-immune depleted; and 
(lanes 9-12) hPrpl8-immunodepleted 
HeLa cell nuclear extracts. Forlanes 13- 
16, purified recombinant hPrpl8 (with a His tag) was added to the hPrpl8-depleted extract for the splicing assay. The reactions were 
allowed to run for the times shown (in min) at the top of each lane. The positions of the lariat intron-exon2 intermediate, pre-mRNA, 
mRNA, intron, and exonl intermediate (listed from top to bottom) are shown. 
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F igure 3. (A) Chasing of intermediates to 
products by addition of hPrpl8. ~-Globin 
pre-mRNA was spliced in a HeLa cell 
nuclear extract immunodepleted of 
hPrp 18. Splicing was carried outfor 90 min 
in parallel samples (lanes 1,2,5-8). hPrpl8 
protein was added to these reactions and 
incubation was continued for 4 min (lane 
5), 8 min (lane 6), 16 min (lane 7), or 30 rain 
(lane 8). Lane 2 shows a 30-min incubation 
without added hPrpl8, and lanes 3 and 4 
show splicing by extract reconstituted 
with hPrpl8 before the addition of sub- 
strate. The positions of the RNAs are indi- 
cated as in Fig. 2B. The times shown at the 
top of each lane are the total reaction 
times for each sample. (B)Quantitation of
the chasing reaction. The amounts of three 
RNAs, the pre-mRNA (shaded), the lariat 
intron-exon2 intermediate (hatched), and 
the mRNA (black), from lanes 1,4-8, and 2 
in A were measured. The molar amount of 
RNA was normalized to the amount of 
pre-mRNA present at the beginning of the 
chase. Timeis indicated in min after the 
addition of hPrp 18. 
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shown). To increase the fraction of spliceosomes avail- 
able for hPrpl 8 binding, splicing reactions were carried 
out in hPrp 18-depleted extracts. Spliceosomes capable of 
binding hPrpl 8 were then captured by hPrp 18 immobi- 
lized on anti-hPrpl8-protein A-Sepharose. With this 
procedure, substantial fractions (20%-30%) of both the 
lariat intron-exon2 and exonl intermediates were bound 
to the hPrpl8-resin (Fig. 4, lanes 3,5), implying that 
hPrpl8 is a stable component of the spliceosome before 
the second transesterification reaction. The precipita- 
tion of the RNAs by hPrpl8 did not depend on ATP. 
Only -3% of the pre-mRNA was precipitated (Fig. 4, 
lanes 3,5), and similar amounts of pre-mRNA were pre- 
cipitated in control samples (Fig. 4, lanes 7,9). 
Significant amounts of the two products, mRNA and 
intron, were also precipitated (Fig. 4, lanes 3,5). Under 
the precipitation conditions, the splicing reaction pro- 
ceeded, and spliced products were formed from the splic- 
ing intermediates when hPrp 18 was present (Fig. 4, lanes 
3,5,10). This chasing apparently occurred in spliceo- 
somes bound to the resin, as much of the product re- 
mained bound, although the possibility that released 
hPrpl8 effected the chase in solution and then rebound 
to the column cannot be excluded. In the absence of ATP 
(Fig. 4, lanes 5,6,10), small amounts of spliced products 
(both mRNA and intron) were formed, and -30% of these 
were bound to the column. In the presence of ATP (Fig. 
4, lanes 3,4), more products were formed and -15% of 
these were bound; the amounts of both splicing interme- 
diates declined (to levels similar to those in lane 2 of Fig. 
4), but commensurate amounts of products were not 
seen. Instability of products under the dilute precipita- 
tion conditions is the most likely explanation of this 
observation, because the intermediates were stable in 
other samples (Fig. 4, lanes 8,10). The control samples 
showed that precipitation of splicing intermediates or 
products required both added hPrpl8 protein (Fig. 4, 
lanes 7,8) and anti-hPrpl8 (Fig. 4, lanes 9,10). 
Splicing of several pre-mRNAs was assayed in hPrp 18- 
depleted extracts to determine whether hPrpl8 is a gen- 
eral splicing factor. In all of the RNAs studied, including 
the ~-thalassemia WS1-G1 ~ A (Fig. 5A) (Krainer et al. 
1984), ftz (Fig. 5B)(Rio 1988), adenovirus E1A (Fig. 5C) 
(Schmitt et al. 1987), two ~-tropomyosin RNAs, p7(8/9) 
(Fig. 5D)and p2p6(8/9)pU (data not shown)(Tsukahara et 
al. 1994), and adenovirus major late (data not shown) 
(Michaud and Reed 1993), the second step of splicing was 
substantially inhibited by depletion of hPrp18 and was 
restored by addition of hPrp 18, showing the involvement 
of hPrpl 8 in the splicing of all of these substrates. Some 
residual second-step activity was seen in hPrpl8-de- 
pleted extracts [Figs. 2B (lane 12) and 5]; the amount of 
activity varied somewhat with different substrates. 
The effect of hPrp 18 on alternative splicing was tested 
on pre-mRNAs with duplicated 5' or 3' splice sites (Reed 
and Maniatis 1986; Krainer et al. 1990), as well as the 
~-thalassemia, denovirus, and ~-tropomyosin RNAs 
mentioned above. Varying the concentration of hPrp18 
did not affect splice site selection in any of these sub- 
strates. The results on splicing of various transcripts sug- 
gest that by itself hPrpl8 does not affect alternative 
splicing. 
Functional interchangeability of human and yeast 
Prp l 8 proteins 
To assess the functional relationship of hPrp 18 and yeast 
Prpl8, we carried out both in vitro and in vivo comple- 
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Figure 4. Precipitation of spliceosomes by immobilized 
hPrpl8, f~-Globin pre-mRNA was spliced for 90 min in a HeLa 
cell nuclear extract depleted of hPrpl 8, forming splicing inter- 
mediates (lane 1). The intermediates could be chased to prod- 
ucts by the addition ofhPrpl8 (lane 2). Parallel reactions, used 
for the precipitations, were treated as follows: diluted in splic- 
ing buffer, mixed with hPrp 18-anti-hPrp 18-protein A-Sepha- 
rose, and separated into (lane 3) a bound fraction a d (lane 4) an 
unbound fraction; diluted in ATP-depleting splicing buffer, 
mixed with hPrpl8-anti-hPrpl8-protein A-Sepharose, and 
separated into (lane 5) a bound fraction a d (lane 6) an unbound 
fraction; diluted in splicing buffer, mixed with anti-hPrp 18-pro- 
tein A-Sepharose (lacking hPrpl8 protein), and separated into 
(lane 7) a bound fraction and (lane 8) an unbound fraction; di- 
luted in ATP-depleting splicing buffer, mixed with hPrp 18 pro- 
tein and pre-immune-antibody-protein A-Sepharose, and sepa- 
rated into (lane 9) a bound fraction a d (lane 10) an unbound 
fraction. Only one-quarter of the samples in lanes 1,2,4,6,8, and 
10 was loaded on the gel to facilitate comparisons withthe 
bound fractions. The positions of the RNAs are indicated as in 
Fig. 2B. The RNAs that migrated between intron and exonl 
appear to be short lariats, resulting from degradation of l r at 
intron-exon2 intermediates. Splicing was less efficient than that 
shown in other figures because polyvinylalcohol, which nonspe- 
cifically increased the background precipitation, was omitted. 
mentation experiments. In one in vitro test, yeast Prpl 8 
protein (Horowitz and Abelson 1993b) was added to 
HeLa cell nuclear extract depleted of hPrpl8 (described 
above). Yeast Prpl8 was able to restore splicing activity 
to this extract (Fig. 6A, lanes 5,6), although somewhat 
less efficiently than hPrpl8 (Fig. 6A, lanes 3,4). A trivial 
explanation of the activity of yeast Prpl8--that trace 
amounts of hPrpl8 were displaced from residual anti- 
hPrpl8 by the added yeast Prpl8--is very unlikely, be- 
cause anti-hPrp 18 does not cross-react with yeast Prp 18 
A human second-step splicing factor 
on Western blots and because the levels of hPrpl8 and 
anti-hPrpl8 in the depleted extract are extremely low 
(neither protein could be detected; Fig. 2A). 
We tried to replace yeast Prp18 with hPrpl8 in two 
ways. hPrp 18 was tested for complementation f a yeast 
extract depleted of Prpl8 (Fig. 6B). Depletion of Prp18 
blocked the second step of splicing almost completely 
(Fig. 6B, lanes 1-3), as reported in Horowitz and Abelson 
(1993a), and full activity was restored on addition of 
yeast Prp18 (Fig. 6B, lanes 4-6). Addition of hPrpl8, in 
contrast, did not restore the second step of splicing (Fig. 
6B, lanes 7-9), indicating that hPrpl 8 is inactive in yeast 
splicing in vitro, hPrp 18 was also tested for complement- 
ing activity in vivo. The hPrpl8 protein was expressed 
from single- or multicopy plasmids in a yeast strain tem- 
perature-sensitive for growth because of the disruption 
of its PRP18 gene (Horowitz and Abelson 1993b). hPrp 18 
did not rescue the yeast cells at nonpermissive t mpera- 
tures, whereas yeast Prpl8 did (data not shown). Expres- 
sion of hPrpl8 had no evident effect on yeast growth at 
permissive temperatures. Both the in vitro and in vivo 
results show that hPrpl8 cannot substitute for yeast 
Prp 18. 
Association of hPrpl8 and the 55-kD protein with the 
snRNPs 
Several methods were used to determine whether hPrp 18 
is associated with any of the snRNPs. First, snRNPs 
were fractionated by glycerol gradient sedimentation to
resolve the U1, U2, U4/U6, Ub, and U4/U6 9 U5 snRNPs 
from one another, as determined by Northern blotting of 
the snRNAs (Fig. 7A)(Black and Pinto 1989; Behrens and 
L~ihrmann 1991). The position of hPrp18 was deter- 
mined by Western blotting of gradient fractions (Fig. 7B). 
hPrpl 8 was found only at the top of the gradient, indi- 
cating that the vast majority of hPrpl8 was not stably 
bound to any of the snRNPs. Under all of the tested 
conditions, we found that hPrpl8 remained principally 
at the top of the gradient and did not comigrate with any 
of the snRNPs. Second, snRNAs were immunoprecipi- 
tated with antitrimethylguanosine under conditions 
where the snRNPs remain intact (Krainer 1988). No sig- 
ificant amount of hPrp18 was precipitated with the 
snRNPs (assayed by Western blot; data not shown), con- 
sistent with the glycerol gradient results. Finally, no 
hPrpl8 was found in a preparation of purified U4/ 
U6. U5 snRNPs (data not shown; Behrens and L~ihr- 
mann 1991). All of the results are consistent with the 
conclusion that hPrp 18 is not stably associated with any 
of the snRNPs. 
The experiments on snRNPs showed unexpectedly 
that the 55-kD protein that cross-reacted with anti- 
hPrpl8 is part of the U4/U6 snRNP. In glycerol gradient 
fractionation, the 55-kD protein cosedimented with U4/ 
U6 and U4/U6 9 Ub. The 55-kD protein peaked in frac- 
tions 17 and 18 at the same place as the U4/U6. U5 
snRNP (Fig. 7). A smaller peak of 55-kD protein was seen 
in fractions 10-12, comigrating with the similarly small 
peak of U4/U6 snRNP. Unbound 55-kD protein re- 
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F igure 5. Splicing of different pre- 
mRNAs in hPrp 18-depleted xtract. Splic- 
ing was assayed on four substrates: (A) 
~-thalassemia (~-globin IVS1-G1 --~ A); (B) 
ftz exons 1 and 2; (C) adenovirus E1A; and 
(D) ~-tropomyosin exons 7 and 8/9. Each 
panel shows the products of three splicing 
reactions using untreated extract (lane 1); 
hPrpl8-immunodepleted extract (lane 2); 
and hPrpl8-depleted xtract plus hPrpl8 
protein (lane 3). The positions of the vari- 
ous RNAs are shown. The mRNAs result- 
ing from use of cryptic sites 1, 2, and 3 
(crl, cr2, and cr3) in the ~-thalassemia pre- 
mRNA are indicated (A). The cr2 site is 
dominant and only its intermediates can 
be identified readily; the band correspond- 
ing to the crl lariat intermediate is also 
indicated. The intermediates and products 
in splicing of E1A (C) were assigned by 
comparison with Schmitt et al. (1987). The 
13S lariat intermediate and product were 
reported previously to be multiple bands. 
Part of the gel has been omitted; the bot- 
tom panel in C, showing the 13S lariat, is 
from a slightly darker exposure than the 
top one. The bands marked with an aster- 
isk were noted but not assigned in Schmitt 
A I~-thalassemia B ftz C adenovirus E1A D I~-tropomyosin 
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et al. (1987). More activity is seen with untreated extract (lane 1) than with restored extract (lane 3) because of nonspecific reduction 
in activity caused by the depletion procedure (also seen for B-globin in Fig. 2). 
mained at the top of the gradient. The protein was also 
efficiently coprecipitated with the snRNPs by antitri- 
methylguanosine (Krainer 1988) and was present in pu- 
rified U4/U6 9 U5 snRNP (Behrens and Lfihrmann 1991). 
These results show that the 55-kD protein is associated 
with the U4/U6 snRNP. 
Antibodies raised against hPrpl 8 were used to immu- 
noprecipitate snRNAs from nuclear extract (Fig. 8). Pri- 
Figure 6. (A) Reconstitution of human splicing 
activity with yeast Prp 18. Splicing of ~-globin pre- 
mRNA in HeLa cell nuclear extract depleted of 
hPrpl8 (lanes 1,2), with hPrpl8 (lanes 3,4), or with 
yeast Prpl8 (lanes 5,6), carried out for the indi- 
cated times. The positions of the RNAs are indi- 
cated as in Fig. 2B. In this assay, splicing with 
yeast Prp 18 produced -40 % as much mRNA (with 
a concomitant reduction in lariat intron-exon2 
and exonl intermediates) as did splicing with 
hPrpl8. Yeast Prpl8 did not affect he first step of 
the reaction. (B) Attempt to reconstitute yeast 
splicing activity with hPrpl8. Splicing of actin 
pre-mRNA in a yeast extract immunodepleted of 
Prpl8 (lanes 1-3), with yeast Prpl8 (lanes 4-6), or 
with hPrpl8 (lanes 7-9), carried out for the indi- 
cated times. Splicing in pre-immune-depleted ex- 
tract is also shown (lanes 10-12). The positions of 
the RNAs are indicated. Lanes 1-3 are virtually 
indistinguishable from lanes 7-9, suggesting that 
hPrpl8 is inactive in yeast splicing, hPrp18 did 
not affect either step of splicing of actin pre- 
mRNA in a normal yeast extract (data not shown). 
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Figure 7. (A) Northern blot of glycerol gradient fractions. HeLa 
cell nuclear extract was pre-incubated under splicing conditions 
and then fractionated in a glycerol gradient (Black and Pinto 
1989). Fraction numbers are shown along the bottom. The U1, 
U2, U4, U5, and U6 snRNAs from each fraction were separated 
on a denaturing polyacrylamide g l and detected by Northern 
blotting. The U1 snRNP (fractions 6-8) and the U2 snRNP (frac- 
tions 12-13) sediment as individual particles. U4 and U6 sedi- 
ment together as a single particle, giving the small peak in frac- 
tions 10-12 and a larger peak in fractions 17-18, together with 
U5 in the U4/U6. U5 snRNP particle. Free U5 snRNP sedi- 
ments just behind the U4/U6 9 U5 snRNP, peaking in fraction 
15. The relative sedimentation f the snRNPs is consistent with 
other reports (Black and Pinto 1989; Behrens and Lfihrmann 
1991). (B) Western blot f glycerol gradient fractions. Glycerol 
gradient fractions were probed with antibody against hPrpl8. 
Cross-reactivity with the 55-kD protein is discussed in the text. 
Fraction numbers are shown along the bottom. 
marily the U4 and U6 snRNAs were precipitated at mod- 
erate salt concentrations (100-400 mM). The immuno- 
precipitation of U4 and U6 was specific but inefficient: 
Less than 1% of the U4 or U6 snRNA present in the 
extract was precipitated. Precipitation of U4 and U6 was 
not affected by preincubation of extracts under splicing 
conditions. The U1 and U2 snRNAs were precipitated 
only at low salt (50 mM), probably through weak inter- 
actions with the U4 and U6 snRNPs. Precipitation f 
small amounts of U5 snRNA at 100-150 mM salt is prob- 
ably attributable to the association of the U5 snRNP 
with the U4/U6 snRNP (Will and Lfihrmann 1996). At 
600 mM salt, more U5 was precipitated than at lower salt 
concentrations. This precipitation was seen at salt con- 
centrations up to 1200 mM (data not shown) and was 
abolished by preincubation of extracts under splicing 
conditions. We believe that the U4 and U6 snRNPs are 
coimmunoprecipitating with the 55-kD protein, consis- 
tent with our other results. The low efficiency of the 
immunoprecipitation could result from the failure of 
anti-hPrpl8 to recognize the native 55-kD protein effi- 
A human second-step splicing factor 
ciently (as in the immunodepletions; see Fig. 2A). How- 
ever, we cannot exclude the possibility that hPrpl8 
binds to the U4 or U6 snRNP in amounts too small to be 
detected in the glycerol gradients and that it mediates 
the coimmunoprecipitation. 
We do not know whether the 55-kD protein is related 
to hPrp 18. All of the polyclonal antibodies raised against 
hPrp18 (two in rabbits, one in mice) cross-reacted with 
the 55-kD protein. However, we did not find any direct 
evidence to suggest hat it is related to hPrp 18. Only one 
mRNA was detected in northern blots using hPrpl8 
cDNA as the probe, suggesting that there are no alterna- 
tively spliced forms of hPrp 18. Two results uggest hat 
the 55-kD protein is not a posttranslationally modified 
form of hPrpl8: first, His-tagged hPrp18, added to HeLa 
cell extracts under conditions where it is active in splic- 
ing, was not modified to any forms with different elec- 
trophoretic mobilities; and, second, in vitro translation 
in rabbit reticulocyte or wheat germ extract gave only 
the 40-kD product expected for hPrpl 8. Curiously, anti- 
body against yeast Prpl8 reacts with a 54-kD human 
protein, called p54 nrb, that is closely related to the splic- 
ing factor PSF (Dong et al. 1993). Recombinant p54 nrb 
was not recognized by antibody against hPrp18, indicat- 
ing that the new 55-kD protein is distinct from p54 n~b. 
Discuss ion  
We have identified and characterized a new human pre- 
mRNA splicing factor required for the second catalytic 
step of splicing. The new protein, hPrpl8, was found 
using degenerate PCR based on the sequences of yeast 
Prpl8, a rice EST, and a nematode EST. Homology be- 
tween hPrpl8 and yeast Prpl 8 is strong only in part of 
the protein, yet the yeast protein can substitute for the 
human one in human splicing. In HeLa cell nuclear ex- 
tracts immunodepleted of hPrpl8, the first step of splic- 
ing proceeds normally, but the second step is blocked. 
< 
pre-immune a-hPrp18 z n* 
NaCl  i ~ j i' ol "~ 
U2- 
U1- 
U4- 
U5- 
U6- 
Figure 8. Immunoprecipitation of snRNAs by anti-Prpl8, snRNAs 
were immunoprecipitated from HeLa cell nuclear extract using 
pre-immune antibodies or antibodies raised against hPrpl 8. Salt 
concentrations varying from 50 to 600 mM were used, as indi- 
cated at the top of each lane. A Northern blot of the precipitated 
snRNAs is shown. The positions of the five snRNAs probed are 
indicated. In the lane showing total RNA, only one-fifth of the 
amount of sample used for each of the immunoprecipitations 
was loaded. 
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Addition of purified hPrpl8 protein to depleted extracts 
restores full splicing activity, proving that hPrpl8 is a 
second-step splicing factor. The splicing intermediates 
formed in the absence of hPrpl8 can be chased to prod- 
ucts by hPrpl8, showing that the spliceosomes contain- 
ing these intermediates are functional and suggesting 
that they are normal intermediates in the splicing path- 
way. 
hPrp 18 is required for the second step of splicing of all 
of the pre-mRNAs we tested, strongly suggesting that 
hPrpl8 is a general splicing factor. A small amount of 
product mRNA was observed in the splicing of each of 
the pre-mRNAs in hPrpl8-depleted extracts; different 
pre-mRNAs gave slightly different amounts of residual 
second-step activity, but we did not find any pre-mRNA 
that spliced efficiently in depleted extracts. The residual 
activity may result from traces of hPrpl 8 remaining in 
the extract, although none was detected by Western blot. 
Alternatively, the residual activity may be from hPrpl 8- 
independent splicing, as was seen in yeast, in which 
Prpl8 is not absolutely required and splicing occurs 
slowly without it (Horowitz and Abelson 1993a,b). 
The first evidence that there are factors specific to the 
second step of splicing was obtained by biochemical 
methods (Krainer and Maniatis 1985; Perkins et al. 
1986). However, the complete purification of these ac- 
tivities has not been reported. Recently, an activity re- 
quired for the second step of splicing has been partly 
characterized (Lindsey et al. 1995). This activity was able 
to chase spliceosome-bound i termediates toproducts in 
the absence of ATP, also a property of hPrpl 8 and yeast 
Prpl8 as well as yeast Slu7 (Horowitz and Abelson 
1993a; Ansari and Schwer 1995; Jones et al. 1995). Two 
observations suggest hat hPrpl8 is distinct from, or is 
only a part of, this activity. First, yeast Prpl8 could not 
substitute for the activity (Lindsey et al. 1995) (in con- 
trast to our results for hPrp 18), and second, the activity is 
found in a large particle (Lindsey et al. 1995), whereas 
hPrp 18, which is found at the top of glycerol gradients, 
does not appear to be part of a complex. 
Recent work has suggested that two proteins are in- 
volved in the second step of splicing. A 200-kD, U5 
snRNP-associated protein has been implicated in the 
second step of splicing by antibody-inhibition experi- 
ments (Lauber et al. 1996). However, the yeast homolog 
of the U5-200-kD protein is required for the first step of 
splicing in vivo (Lauber et al. 1996; Noble and Guthrie 
1996) and in vitro (Xu et al. 1996). The results for the 
yeast protein support he idea (Lauber et al. 1996) that 
the antibody inhibition experiments may have uncov- 
ered only part of the function of the human U5-200-kD 
protein or that the second step may have been inhibited 
indirectly by steric hindrance of splicing by antibodies 
within the spliceosome. 
The PSF protein has also been implicated in the second 
step of splicing (Gozani et al. 1996), although igh levels 
of anti-PSF also block the first step (Patton et al. 1993). 
To date, PSF has only been shown to be required for the 
splicing of a pre-mRNA derived from the c,-tropomyosin 
pre-mRNA; the substrate has an unusual branch point, 
located far from the 3' splice site, just upstream of a 
second pyrimidine tract (Smith and Nadal-Ginard 1989). 
Because PSF binds preferentially to RNAs with pyrimi- 
dine tracts (Patton et al. 1993), it may only be required 
for splicing of specific RNAs with such tracts. Therefore, 
hPrpl 8 may be the first general second-step factor found 
in humans. 
Isolation of spliceosomes containing splicing interme- 
diates has allowed the identification of several proteins 
that join the spliceosome after the initial steps of splice- 
osome assembly (Gozani et al. 1994). Based on their mo- 
lecular weights, two of these proteins, a 40-kD U5 
snRNP protein (Bach et al. 1989) and SAP45, could be 
hPrpl8. However, the 40-kD protein is not hPrpl8, as 
the 40-kD protein is present in the purified U4/U6 9 U5 
snRNPs that we tested (Behrens and Lfihrmann 1991) 
but is not detected by anti-hPrpl 8; in addition, the elec- 
trophoretic mobilities of the 40-kD protein and hPrpl8 
are slightly different. We do not know whether hPrp 18 is 
the same as SAP45. 
hPrp 18 binds transiently to the spliceosome during the 
second step of splicing. From splicing reactions done 
with hPrpl8-depleted extract, splicing intermediates 
could be efficiently precipitated on immobilized hPrp 18. 
Some of the spliceosomes bound to the immobilized 
hPrpl8 carried out the second step of splicing, forming 
products that remained bound to the column. In con- 
trast, from normal splicing reactions, only a very small 
fraction of any splicing RNA could be precipitated with 
anti-hPrpl8, hPrpl8 apparently binds the spliceosome 
tightly only at the point in the splicing reaction when it 
is needed. The low yield of immunoprecipitations from 
standard splicing reactions implies that the association 
of hPrpl8 with the spliceosome is normally short-lived; 
even among spliceosomes containing intermediates or 
products, only a small fraction appear to contain hPrp 18. 
The results support a model in which hPrpl8 binds to 
the spliceosome just before the second transesterifica- 
tion reaction, after other stages within the second step. 
Following the reaction, hPrpl8 remains bound to the 
spliceosome bearing the products, but it is eventually 
released, perhaps when the spliceosome disassembles. 
Two second-step factors in yeast associate transiently 
with the spliceosome. The Prp 16 protein binds to splice- 
osomes containing intermediates, catalyzes a conforma- 
tional change in the spliceosome fueled by ATP hydro- 
lysis, and then leaves the spliceosome (Schwer and 
Guthrie 1991, 1992; Brys and Schwer 1996). Prpl6 acts 
before Prpl 8 (Horowitz and Abelson 1993a) and does not 
appear (by immunoprecipitation) to be part of the splice- 
osome at the time of the second transesterification reac- 
tion. The Slu7 protein acts after Prpl6, at the same stage 
of the second step as Prpl8 (Ansari and Schwer 1995; 
Jones et al. 1995). Strong binding of Slu7 to the spliceo- 
some depends on Prpl6, and Slu7 remains bound to the 
spliceosome during the second reaction (Brys and Schwer 
1996). Release of Slu7 from the spliceosome occurs only 
on disassembly of the spliceosome. Our results on spli- 
ceosome binding by hPrp18 closely parallel those for 
Slu7. The behavior of the Prp8 protein is different; it 
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appears to be associated stably with the spliceosome 
throughout the splicing reaction (Whittaker et al. 1990). 
One possible site of binding of hPrpl8 in the splice- 
osome is the U5 snRNP. Yeast Prpl8 is associated with 
the U4/U6. U5 snRNP, primarily through interaction 
with the U5 snRNP (Horowitz and Abelson 1993b). 
However, the results for hPrpl8 are different, and we 
found no evidence of a stable association between 
hPrpl 8 and any of the snRNPs. Although the difference 
in snRNP-binding properties of hPrp18 and Prpl 8 may 
reflect a fundamental difference in the mechanisms of 
action of the two proteins, the functional interchange- 
ability of the proteins in human splicing argues that they 
are mechanistically similar. Prpl8 is not bound tightly 
to U4/U6 9 U5, compared with other yeast proteins uch 
as Prp4 and Prp24 (Banroques and Abelson 1989; Pe- 
tersen-Bjorn et al. 1989; Shannon and Guthrie 1991), and 
we suspect hat in hPrpl8 these interactions have been 
weakened further. 
Antibodies raised against hPrpl8, a 40-kD protein, 
cross-react with a 55-kD protein on Western blots. Al- 
though we do not know what the relationship of the 
55-kD protein is to hPrpl8, the 55-kD protein does not 
appear to be either a modified form or an alternatively 
spliced form of hPrpl8. The 55-kD protein is associated 
with the U4/U6 snRNP. Two other U4/U6-specific pro- 
teins are known, one of 60-kD and one of 90-kD, but 
neither has been characterized (Gozani et al. 1994). From 
their electrophoretic mobilities, it is possible that the 
55-kD and 60-kD protein are the same. Three other 
snRNP proteins of 60 kD have also been reported; they 
appear to be part of the U4/U6 9 U5 snRNP (Behrens and 
L~ihrmann 1991; Will and L~hrmann 1997). Five proteins 
associated specifically with U4/U6 are known in yeast 
(Banroques and Abelson 1989; Petersen-Bjorn etal. 1989; 
Abovich et al. 1990; Shannon and Guthrie 1991; Cooper 
et al. 1995). 
The interchangeability of hPrpl 8 and yeast Prpl 8 in 
human splicing was surprising iven the relatively weak 
overall similarity of their sequences (Fig. 1A). During the 
second step of splicing, hPrp 18 is likely to interact with 
several components of the spliceosome. Yeast Prpl8 
binds to the U4/U6 9 U5 snRNP (Horowitz and Abelson 
1993b), and genetic experiments suggest hat it inter- 
acts with the Prp 17 and Slu7 proteins, as well as the U5 
snRNA (Frank et al. 1992; Jones et al. 1995), and we 
expect hat hPrpl8 would require similar interactions. 
We do not know why the complementation results in 
human and yeast splicing are asymmetric. The r place- 
ment of hPrp 18 with yeast Prp 18 in human splicing im- 
plies that they function very similarly and that they 
share many structural features. The failure of hPrp 18 to 
function in yeast splicing may be attributable to minor 
functional differences in the proteins or to technical dif- 
ficulties in the experiments (for example, instability of 
the protein or improper protein localization). A possible 
explanation for the failure of hPrp 18 to function in yeast 
is that yeast splicing may require a stronger interaction 
between Prpl8 and the U4/U6 9 U5 snRNP. Despite the 
conservation of at least one portion of hPrpl8 in yeast 
Prpl8, hPrpl8 did not function as a dominant negative 
allele of PRP18 in yeast; such a result might be expected 
if a conserved part of hPrp 18 interacted with, and seques- 
tered, another essential splicing factor. 
The complementation results imply that important 
functional domains of hPrpl8 are conserved in Prp18. 
Figure 1A shows that strong homology between the two 
proteins is restricted to the carboxy-terminal part of the 
proteins. Within the boxed portion of the sequences, 
40% of the amino acids are identical; however, outside 
this region the alignment is weak, implying that the car- 
boxy-terminal domain is critical for the functioning of 
hPrp 18. The alignment of the carboxyl termini of hPrp 18 
and yeast Prpl8 with the rice and nematode EST se- 
quences (Fig. 1B) shows that this region is highly con- 
served among all the proteins. Homology is focused in 
two areas, from amino acids 273-291 and from 303-324, 
where a consensus equence can be readily derived. Al- 
though a variety of search programs failed to find other 
proteins related to these in the current data bases, we 
suggest that this alignment defines a new protein motif. 
Neither our data nor the data base searches suggest what 
the function of this evolutionarily conserved region is. It 
may be involved in interaction with proteins or RNAs, 
or it may carry out a specific task in the splicing reac- 
tion. 
Several other homologous splicing proteins in humans 
and yeast have been identified. These include compo- 
nents of the SF3a and SF3b complexes, which act early in 
the spliceosome assembly pathway (Behrens et al. 1993; 
Bennett and Reed 1993; Brosi et al. 1993; Kr~imer et al. 
1995; Gozani et al. 1996; Wells et al. 1996); four snRNP 
proteins (Smith and Barrell 1991; Liao et al. 1993; Ry- 
mond et al. 1993; Polycarpou-Schwarz et al. 1996); and a 
member of the DEAH protein family (called HRH1) that 
functions in spliceosome disassembly (Ono et al. 1994). 
The recently identified human U5-200-kD protein, 
whose yeast homolog is known as Brr2, Slt22, or Snu246 
(Noble and Guthrie 1996; Xu et al. 1996), is both a DEXH 
protein and a snRNP-associated protein (Lauber et al. 
1996). A homolog of Prp8, which is involved in both 
steps of splicing, has been identified using antibodies 
(Pinto and Steitz 1989; Garcia-Blanco et al. 1990; Hodges 
et al. 1995). In these homologs, overall sequence identity 
(when known) ranges from 25% to 45%. The human 
snRNP D1 protein (Rymond et al. 1993), and the HRH1 
protein (Ono et al. 1994), two of the most conserved ho- 
mologs, are functional in vivo in yeast. However, Prpl 8 
is the only yeast splicing factor demonstrated to function 
in human splicing. 
Although pre-mRNA splicing in yeast and mammals 
follows similar overall pathways, there are some notable 
differences. The mechanism for recognizing splice sites 
in mammals, which allows for wide variation in splice- 
site sequences and for regulated alternative splicing, is 
more complex than that of yeast, where splice-site se- 
quences are nearly invariant and alternative splice-site 
selection is absent (Horowitz and Krainer 1994; Black 
1995). Identification of 3' splice sites, which occurs dur- 
ing the second step, is likely, therefore, to occur by 
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somewhat  different mechan isms in mammals  and yeast. 
Previous work on the second step of splicing in mam- 
mals has focused on the snRNAs and the pre-mRNA. 
Experiments on the U2 and U6 snRNAs, wh ich  are both 
required for the second step of splicing, have general ly 
supported the conservation of splicing mechan ism be- 
tween yeast and humans  (Fabrizio and Abelson 1990; 
Shuster and Guthr ie  1990; Datta and Weiner 1993; Wolff 
et al. 1994; Ares and Weiser 1995). In the work reported 
here, we have characterized a protein required for the 
second step. The conservation of its funct ion between 
yeast and humans  shows the close phylogenetic onser- 
vat ion of the mechan ism of the splicing reaction. 
Materials  and methods  
Identification and cloning of the hPrpl8 cDNA 
Alignment of the yeast (L03536), nematode (T01256), and rice 
(D15798) sequences was the basis for designing two oligo- 
nucleotides, 5'-CGGAATTCGC(I/C)AT(I/C)GG(I/C)AATGC 
(I/C)CC(I/C)TGGC-3' and 5'-CGGGATCCGATGTATTT(G/ 
T)CI(G/T)ITIGT(T/C)TCGTC-3' (corresponding to amino acids 
187-194 and 230-222 of the yeast sequence), that were used for 
PCR of human cDNA. A fragment of the expected size was 
generated; its sequence could be aligned with the yeast, rice, and 
nematode peptide sequences. Two oligonucleotides correspond- 
ing to portions of this fragment were used to screen a ~ HeLa 
eDNA library. The resulting clone, containing a 1450-bp insert, 
was sequenced (accession o. U51990). A Northern blot of 
poly(A) + RNA from HeLa cells gave a single, diffuse band of 
-1600 bases, suggesting that the DNA clone was full-length. 
The first ATG codon in the hPrpl8 sequence was presumed to 
be the correct one based on its frame and context (Griinert and 
Jackson 1994); protein produced in E. coli comigrated exactly 
with HeLa cell protein detected by Western blots. Several hu- 
man ESTs that overlap the sequence of hPrpl8 have been re- 
ported since the completion of this work. The EST sequences 
are 96%-99% identical to our hPrpl8 sequence. Analysis of the 
DNA and protein sequences was done using the GCG package 
(Genetics Computer Group 1994). 
Production of recombinant hPrp18 and antibodies 
The hPrpl8 protein with or without an amino-terminal o igo- 
histidine tag was made in E. coli using the T7 expression vectors 
pET9c and pET19b (Novagen). His-tagged hPrpl8, which 
formed inclusion bodies, was purified to near homogeneity by 
immobilized metal-ion affinity chromatography in 6 M 
guanidinium 9 HC1 (Petty 1993) and then renatured by dialysis 
against 25 mM Tris at pH 7.5, 250 mM NAG1, 1 mM EDTA, 1 mM 
DTT, and 10% glycerol. The purified protein was mostly 
soluble and was stable for > 1 year at 4~ The His-tagged hPrpl8 
was used for raising antibodies and for functional studies. 
Immunodepletion f hPrp l 8 
hPrpl8 was immunodepleted from HeLa cell nuclear extracts by 
incubating extracts with one-fifth volume of protein A-Sepha- 
rose-bound antibodies in 20 mM HEPES at pH 7.9, 750 mM KC1, 
10% glycerol, 1 mM DTT, 0.2 mM EDTA, 0.1 mM PMSF for 1 hr 
at 4~ twice, followed by incubation with one-tenth volume 
protein A-Sepharose in the same buffer for 30 min to remove 
any released antibody. The depleted extract was dialyzed 
against he same buffer with 100 mM KC1. Immunoprecipita- 
tions from 3SS-labeled nuclear extract showed that hPrpl8 was 
the predominant precipitated protein. The 55-kD protein could 
not be detected in Western blots of the proteins immunopre- 
cipitated under hPrpl8-depletion conditions. 
Splicing assays 
Splicing in HeLa-cell nuclear extracts was carried out as de- 
scribed previously (Krainer et al. 1984). For reconstitution of
splicing activity, 10-50 ng purified recombinant hPrpl8 was 
added per microliter of nuclear extract (7 lag protein). From 
Western blots we estimated that the concentration of hPrp 18 in 
our HeLa nuclear extracts was 5 ng/]al; we obtained essentially 
full restoration of splicing with 2 ng of recombinant hPrp 18 per 
microliter extract. For reconstitution of activity with yeast 
Prpl8, 100 ng Prpl8 was added per microliter HeLa nuclear 
extract. Splicing substrates were transcribed from pSP64-H~A6 
(Krainer et al. 1984), pSP64-H~A6WSl-lA (Krainer et al. 1984), 
pSP64-H~5'D16X (Reed and Maniatis 1986; Krainer et al. 1990), 
pSP64-H~3'D115 (Reed and Maniatis 1986; Krainer et al. 1990), 
p7(8/9) (Tsukahara et al. 1994), p2p6(8/9)pU (Tsukahara et al. 
1994), pSP65-SP4 (Schmitt et al. 1987), SP6-ftz (Rio 1988), and 
pAdML (Michaud and Reed 1993). 
Yeast splicing, immunodepletion of Prpl8 from yeast ex- 
tracts, and purification of Prpt8 protein were carried out as 
described previously (Lin et al. 1985; Horowitz and Abelson 
1993a). Forty nanograms hPrpl8 (40 ng) was added per microli- 
ter of yeast extract in our attempt o restore activity to the 
Prp 18-depleted extract. 
Immunoprecipitation of spliceosomes 
Antiserum against hPrpl8 (or pre-immune serum) was incu- 
bated with protein A-Sepharose (3 ~1 serum per microliter 
resin). After extensive washing, the resin was incubated with 
hPrpl8 (50 ng per microliter esin) and washed again, yielding 
hPrpl8-anti-hPrpl8-protein A-Sepharose. Splicing reactions 
were carried out in hPrpl8-depleted extracts for 90 min under 
normal splicing conditions except that polyvinylalcohol was 
omitted, diluted 10-fold either in splicing buffer or in ATP- 
depleting splicing buffer (including lucose and hexokinase, but 
lacking creatine phosphate and ATP; brief incubation in this 
buffer reduced the concentration of ATP to -0.3 ~M), and mixed 
with the hPrp 18-anti-hPrpl 8-protein A-Sepharose (1 ~1 reac- 
tion per microliter esin) for 45 min at 30~ The mixture was 
spun in a microcentrifuge filter, separating the resin from the 
unbound material; the resin was washed once briefly, and the 
wash was removed by filtration and combined with the un- 
bound fraction. Bound RNA was eluted from the resin with 
proteinase K and SDS. 
Expression of hPrpl8 in yeast 
The hPrpl8 gene was placed under control of the GALl pro- 
moter using the plasmids pSEYC68GAL (single copy) and 
pSEY18GAL (multicopy) (Herman and Emr 1990). hPrpl8 did 
not rescue the temperature-sensitive defect of the yeast PRP18- 
knockout strain DH120R (Horowitz and Abelson 1993b) at 
33~ or 37~ under a variety of induction conditions. At 23~ (a 
permissive temperature) expression of hPrpl8 had no apparent 
effect on yeast growth. Expression of hPrpl8 in yeast was veri- 
fied by Western blot. Yeast Prpl8 expressed from analogous 
plasmids always rescued the yeast. 
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Glycerol gradients 
Glycerol gradients were run according to described procedures 
(Black and Pinto 1989; Behrens and L~hrmann 1991), both with 
and without preincubation under splicing conditions. RNAs 
were detected on Northern blots with RNA probes (Konarska 
and Sharp 1987). hPrpl8 and the 55-kD protein were detected by 
Western blotting using enhanced chemiluminescence. 
Immunoprecipitations of nRNPs 
Immunoprecipitations using antibodies against rimethylgua- 
nosine or hPrpl8 were carried out according to procedures de- 
scribed previously (Krainer 1988; Banroques and Abelson 1989; 
Horowitz and Abelson 1993b). 
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